One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

This Morning presenter Ruth Langsford has opened up about her recent weight loss and shared the heartbreaking reason she has ...

They're known to aid in blood sugar control and, now, weight loss — but, according to a sweeping new study, the popular GLP-1 ...

This Morning presenter Ruth Langsford has opened up about her recent weight loss, saying that she thinks her divorce from ...

Finally, a few studies in mice have found that the medications can reduce the buildup of the protein tau in the brain, which is a key contributor to Alzheimer’s disease. Scaling back tau buildup could ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

ALL of us would like to live a healthy life for as long as possible and many tend to assume that life expectancy is largely determined by genetics. However, although there’s no denying that ...

For people with diabetes, the use of GLP-1 RAs is associated with a reduced risk for certain disorders and conditions, including neurocognitive and cardiometabolic disorders, and with an increased ...

Gum disease, or periodontitis, has been linked to poorer cognitive function. Researchers believe this connection may be due ...